MedPath

Effect Of Trumove Gel in reducing muscle and joint Pai

Phase 3
Completed
Conditions
Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified
Registration Number
CTRI/2023/05/052160
Lead Sponsor
Tirupati Pharma, India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1. Patients of either sex aged above 18 years.

2. Patients who are able to understand written and/or verbal instructions and are ready to comply with all study requirements with a willingness to participate and give written informed consent voluntarily.

3. Patients who had been diagnosed with acute and chronic localized musculoskeletal pain and joint pain (arthritis) .

Exclusion Criteria

1. Women of child bearing potential who are either unwilling or

unable to use an acceptable method of birth control to avoid

pregnancy during the study period.

2. Subject with active skin lesions or other skin diseases.

3. Subject with history of uncontrolled diabetes

4. Subject with history of Periarthritis, rheumatoid arthritis

5. Known allergy to compounds of investigational product.

6. Participation in an investigational drug trial in the30 days

prior to the screeningvisit.

7. Patients of vulnerable group (children, lactating mother, elderly

>80 years,handicapped, seriously ill, mentally challenged).

8. History of drug or alcohol abuse during the last 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath